Urinary Metabolomic Profiles of Bladder and Prostate Cancer by LC-HRMS: A Comparative Study

Urinary LC-HRMS metabolomics non-invasively reflects cancer-associated biochemical alterations. However, candidate panels are rarely re-tested in new cohorts or checked against confounding factors, and comparative studies between cancers must differentiate shared from disease-specific changes. We applied a sample preparation and LC-HRMS workflow, previously optimized by design of experiments, to a new cohort of 94 participants (29 bladder cancer, BC; 20 prostate cancer, PC; 45 controls). Data processing combined QC-based filtering, grouping of ions into compounds, exclusion of exogenous signals, adjusted models, matched pairs and cross-validation with permutation testing. After quality filtering, 7403 of 14,693 features were retained (median QC RSD 8.6%). Adjusted for age, sex and exogenous signals, 188 compounds differed between BC and controls. Five were tentatively annotated (MSI levels 2–3): glucuronides of 11-oxoetiocholanolone and tetrahydrocortisone (two isomers), Lysophosphatidylcholine (LysoPC(16:0)) and biliverdin, where 11-oxoetiocholanolone glucuronide was the main candidate. Cross-validated classification of BC gave AUC 0.81 in all samples and 0.68 in matched pairs; these internal estimates require independent validation. An apparent BC-PC separation (AUC 0.86) was not significant after adjustment for exogenous signals, and no PC-specific compounds were found. Controlling for exogenous and demographic factors during data processing gives conservative estimates of urinary metabolomic differences and helps to prevent false-positive findings.

Authors

Institutions

Publication Details

Journal
Analytica—A Journal of Analytical Chemistry and Chemical Analysis
Published
2026-11-18
DOI
https://doi.org/10.3390/analytica7040101
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Urinary Metabolomic Profiles of Bladder and Prostate Cancer by LC-HRMS: A Comparative Study

Игорь Александрович Родин, Mikhail F. Vokuev, А. Н. Ставрианиди, Yuri A. Ikhalaynen et al.
Analytica—A Journal of Analytical Chemistry and Chemical Analysis
Metabolomics and Mass Spectrometry Studies
article

Urinary Metabolomic Profiles of Bladder and Prostate Cancer by LC-HRMS: A Comparative Study

Игорь Александрович Родин, Mikhail F. Vokuev, А. Н. Ставрианиди, Yuri A. Ikhalaynen, Anastasiia Frolova
article en

Abstract

Urinary LC-HRMS metabolomics non-invasively reflects cancer-associated biochemical alterations. However, candidate panels are rarely re-tested in new cohorts or checked against confounding factors, and comparative studies between cancers must differentiate shared from disease-specific changes. We applied a sample preparation and LC-HRMS workflow, previously optimized by design of experiments, to a new cohort of 94 participants (29 bladder cancer, BC; 20 prostate cancer, PC; 45 controls). Data processing combined QC-based filtering, grouping of ions into compounds, exclusion of exogenous signals, adjusted models, matched pairs and cross-validation with permutation testing. After quality filtering, 7403 of 14,693 features were retained (median QC RSD 8.6%). Adjusted for age, sex and exogenous signals, 188 compounds differed between BC and controls. Five were tentatively annotated (MSI levels 2–3): glucuronides of 11-oxoetiocholanolone and tetrahydrocortisone (two isomers), Lysophosphatidylcholine (LysoPC(16:0)) and biliverdin, where 11-oxoetiocholanolone glucuronide was the main candidate. Cross-validated classification of BC gave AUC 0.81 in all samples and 0.68 in matched pairs; these internal estimates require independent validation. An apparent BC-PC separation (AUC 0.86) was not significant after adjustment for exogenous signals, and no PC-specific compounds were found. Controlling for exogenous and demographic factors during data processing gives conservative estimates of urinary metabolomic differences and helps to prevent false-positive findings.

Analytica—A Journal of Analytical Chemistry and Chemical AnalysisVol. 7(4)
Lomonosov Moscow State University (RU), Moscow State University of Fine Chemical Technologies (RU), MIREA - Russian Technological University (RU)
Ministry of Science and Higher Education of the Russian Federation
Good health and well-being
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon